CHEST Journal Podcasts

Informed Consent for Apnea Testing in Patients With Suspected Brain Death?

Ariane Lewis, MD, and Robert D. Troug, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to offer their thoughts from their Point/Counterpoint editorials on whether informed consent should be required for apnea testing in patients with suspected brain death.

Should BAL Be Routinely Performed in the Diagnostic Evaluation of IPF?

Athol U. Wells, MD, and Joshua J Mooney, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate whether bronchoalveolar lavage should be a standard diagnostic tool for IPF. The discussion centers on the lack of evidence-based agreement on the value of performing BAL.

IVIg to Treat Severe Refractory HIT

Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.

Physician Assessment of Probability in Predicting Malignancy and Adherence with Guidelines

Nichole T. Tanner, MD, MSCR, FCCP, and editorialist Jonathan M. Iaccarino, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the accuracy of physician assessment in predicting malignancy in pulmonary nodules. Although adept at recognizing the pretest probability of malignancy, physicians would provide better patient care if they had followed guideline-recommended next steps in evaluation.

Wireless Pulmonary Artery Hemodynamic Monitoring for Pulmonary Hypertension?

Mark J. Zucker, MD, JD, FCCP, and Anne R. Hemnes, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to review the pros and cons of their Point/Counterpoint debate, “Should Wireless Pulmonary Artery Hemodynamic Monitoring Be Used to Monitor Patients With Pulmonary Hypertension?”